Stock Events

Stock Events

Enveric Biosciences 

$1.3700
60
-$0.00-0% 19:59 Today
+$0.02+1.46%22:40After hours

Statistics

Day High
1.39
Day Low
1.34
52W High
17.52
52W Low
1.17
Volume
35,300
Avg. Volume
161,068
Mkt Cap
6.13M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 8
$0.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

12NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
Next
-63
-41.72
-20.43
0.85
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-12.13MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ENVB. It's not an investment recommendation.
Apple
14
AAPL
Tesla
14
TSLA
Palantir Technologies
12
PLTR
Microsoft
11
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap200.76M
Corbus Pharmaceuticals works on developing and commercializing novel therapeutics to treat inflammatory and fibrotic diseases, overlapping with Enveric's target indications.
Aurora Cannabis
ACB
Mkt Cap249.44M
Aurora Cannabis is a major player in the cannabis industry, potentially competing in the medical cannabis space where Enveric operates.
Tilray Brands
TLRY
Mkt Cap665.89M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially overlapping with Enveric's market in cannabinoid-based therapeutics.
Canopy Growth
CGC
Mkt Cap471.76M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing in the broader market for cannabinoid-based products.

About

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
Show more...
CEO
Joseph Edward Tucker
Employees
6
Country
United States
ISIN
US29405E5050
WKN
000A41HB6

Listings

STU
DE
SLZ0.STU
STU
DE
SLZB.STU
MU
DE
SLZ0.MU
XNAS
US
ENVB

0 Comments

Share your thoughts

FAQ

What is Enveric Biosciences stock price today?▼
The current price of ENVB is $1.37 USD — it has decreased by -0% in the past 24 hours. Watch Enveric Biosciences stock price performance more closely on the chart.
What is Enveric Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Enveric Biosciences stocks are traded under the ticker ENVB.
Is Enveric Biosciences stock price growing?▼
ENVB stock has fallen by -1.44% compared to the previous week, the month change is a +2.24% rise, over the last year Enveric Biosciences has showed a -92.13% decrease.
What is Enveric Biosciences market cap?▼
Today Enveric Biosciences has the market capitalization of 6.13M
When is the next Enveric Biosciences earnings date?▼
Enveric Biosciences is going to release the next earnings report on November 12, 2026.
What is Enveric Biosciences revenue for the last year?▼
Enveric Biosciences revenue for the last year amounts to 0 USD.
What is Enveric Biosciences net income for the last year?▼
ENVB net income for the last year is -12.13M USD.
Does Enveric Biosciences pay dividends?▼
Yes, ENVB dividends are paid en. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Enveric Biosciences have?▼
As of August 27, 2026, the company has 6 employees.
In which sector is Enveric Biosciences located?▼
Enveric Biosciences operates in the Health & Wellness sector.
When did Enveric Biosciences complete a stock split?▼
The last stock split for Enveric Biosciences was on October 28, 2025 with a ratio of 1:12.
Where is Enveric Biosciences headquartered?▼
Enveric Biosciences is headquartered in CAMBRIDGE, United States.